It has been found that CPT1 plays a protective role against fatty acid-induced adipocyte dysfunction suggesting that pharmacological activation of CPT1 might represent a promising strategy for the prevention and treatment of obesity related metabolic diseases44. The gene discussed is CPT1A; the disease is obesity disorder.